Refined prognostic score for diffuse large B-cell lymphoma.
Waiting For Required Inputs
Complete the required fields to generate the oncology interpretation.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Use
Refined prognostic score for diffuse large B-cell lymphoma.
Section 2
Formula & Logic
Clinical Inputs
Age
Numeric entry
LDH relative to ULN
Categorical selection
ECOG >= 2
Binary clinical feature
Stage III or IV
Binary clinical feature
Specific extranodal involvement (BM/CNS/liver/GI/lung)
Binary clinical feature
Section 3
Pearls/Pitfalls
Result Bands
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
Refined prognostic score for diffuse large B-cell lymphoma.
OpiCalc Medical Oncology Module • Lymphoma. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
NCCN-IPI (DLBCL) is included in the oncology module as a structured decision-support tool for lymphoma workflows.
